However, some trials of macrolides in COPD specifically excluded patients with bronchiectasis demonstrated by CT scans and, nonetheless, also provided highly significant results in terms of reduction of exacerbations [ 58 ].
← all excerpts
Current Challenges in Chronic Bronchial Infection in Patients with Chronic Obstructive Pulmonary Disease.
1
—
—